AUSTRALIAN DRUG DEVELOPMENT BLOG
The Latest Blogs from Agilex Biolabs
Author By Agilex BiolabsPosted on
By Dr. Kurt Sales, CSO Liquid chromatography-mass spectrometry (LCMS) has become an indispensable tool for the pharmaceutical a...
Author By Agilex BiolabsPosted on
By Dr. Kurt Sales, CSO Preclinical toxicology studies are an essential part of the drug development process as they provide ins...
Author By Agilex BiolabsPosted on
By Dr. Kurt Sales, CSO Biomarkers are playing an increasingly important role in clinical studies where they can provide essenti...
Author By Agilex BiolabsPosted on
by Dr. Kurt Sales, Chief Scientific Officer Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been the preferred an...
Author By Agilex BiolabsPosted on
An exclusive delegation coming from Australia - where leading drug development experts will converge. The Agilex team would lik...
Author By Agilex BiolabsPosted on
Flow cytometry has become a powerful tool in the bioanalytical arsenal. In an era where pharmaceuticals are becoming more targe...
Author By Agilex BiolabsPosted on
Agilex has offered our clients small molecule solutions that lead to their success. Agilex Biolabs is celebrating its 29th year...
Author By Agilex BiolabsPosted on
For 3 decades, Agilex has supported biotech companies with CNS-targeted medicines. For almost 3 decades, Agilex Biolabs has sup...
Author By Agilex BiolabsPosted on
Let's face it – we are an aging population throughout the world. More and more, we are seeing these neurological disorders growi...
Author By Agilex BiolabsPosted on
In molecular biology and pharmacology, small molecules are noted for their ability to quickly modulate their actions. This is beca...
Author By Agilex BiolabsPosted on
Applying Decades of Experience with an Eye on the Future of Small Molecule Development For decades before antibody drugs were d...
Author By Agilex BiolabsPosted on
Looking beyond the surface on the Complexity of Atopic Dermatitis Addressing inflammatory skin disorders like atopic dermatitis...